Digital Health Investors & VC Firms in Italy
15 firms in this list, with a median first check of $540K. 5 of them lead rounds. Generated from verified public data and updated continuously.
XGEN Venture
MilanPre-Seed–Series A
21 people
Neva Sgr.
TurinSeries A–Growth
10 people
Lumen Ventures
RomeSeed
19 people
Angelini Ventures
RomeSeed–Growth
4 people
Gruppo Bertoldi
TrentoSeed–Late Stage
2 people
Utopia
BolognaSeed
4 people
ENEA Tech e Biomedical
Rome
1 person
Innogest Capital
MilanLate Stage
Sofinnova Partners
ParisPre-Seed–Late Stage$540K – $27M
88 people
Planven Entrepreneur Ventures
ZurichSeed–Late Stage$10M – $20M
18 people
InfraVia Capital Partners
ParisSeries C–Late Stage
YZR Capital
MunichPre-Seed–Growth
13 people
Vesper Infrastructure Partners
LondonGrowth–Late Stage
16 people
Connect Ventures
LondonPre-Seed–Series A$500K – $5M
5 people
Chiesi Ventures
BostonSeed–Series A$5M
2 people
Frequently asked questions
- Who are the top digital health investors & vc firms in italy?
- Top digital health investors & vc firms in italy include XGEN Venture, Neva Sgr., Lumen Ventures, Angelini Ventures, Gruppo Bertoldi, Utopia, ENEA Tech e Biomedical, Innogest Capital — 15 firms in total meet the criteria.
- What is the typical first check among digital health investors & vc firms in italy?
- The median first check among the 15 digital health investors & vc firms in italy tracked here is $540K.
- How many digital health investors & vc firms in italy lead rounds?
- 5 of the 15 digital health investors & vc firms in italy tracked here lead investment rounds.
Related lists
Investors & VC Firms in North America (14074)Investors & VC Firms in United States (13215)Investors & VC Firms in Europe (5565)Crypto & Web3 Investors & VC Firms (4819)Investors & VC Firms in Global (4147)SaaS Investors & VC Firms (3842)AI & Machine Learning Investors & VC Firms (3754)Fintech Investors & VC Firms (3710)Investors & VC Firms in Asia-Pacific (3567)Healthtech Investors & VC Firms (3393)
Data sourced from public filings and firms' own websites — see our methodology.







































